Kymera has $900 million in cash and no long-term debt, funding operations into mid-2027. Click here to read an analysis of ...

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...

A2 is in solid financial shape. Apart from NZD 28 million in debt as part of the 75% ownership in Mataura Valley Milk, a2 holds no debt and only minimal operating lease obligations on its balance ...